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Abstract Diversity in parasite virulence is one of the factors
that contribute to the clinical outcome of malaria infections.
The association between the severity of Plasmodium falcipa-
rum malaria and the number of distinct parasite populations
infecting the host (multiplicity of infection) or polymorphism
within any of the specific antigen genes was investigated. The
study included 164 children presenting with mild and severe
malaria from central Uganda where malaria is meso-endemic.
The polymorphic regions of the circumsporozoite protein (csp),
merozoite surface proteins 1 and 2 (msp1 and msp2), and
glutamate-rich protein (glurp) were genotyped by polymerase
chain reaction methods and fragment analysis by gel electro-
phoresis. In a subset of samples fragment analysis was also
performed by fluorescent PCR genotyping followed by capil-
lary electrophoresis. The multiplicity of infection (MOI), deter-
mined as the highest number of alleles detected within any of
the four genetic loci, was significantly higher in severe than in
mild malaria cases (mean 3.7 and 3.0, respectively, P=0.002).
No particular genotype or allelic family of msp1 or msp2 was
associated with severity of malaria, and nor did the genotyping
method reveal any significant difference in MOI when only
assessed by msp2 genotyping. Severity of malaria was not
linked to the predominance of any particular msp1 or msp2
allelic types, independent of methods used for genotyping.
Monitoring the dynamics of multiple clone infections in rela-
tion to disease outcome, host immune status and genetic factors
will provide more insight into parasite virulence mechanisms.
Background
Molecular epidemiological studies of malaria can be used to
study the genetic diversity of infections in relation to various
factors such as transmission intensity, disease phenotype and
host immunity. Individuals infected byPlasmodium falciparum
often consist of genetically distinct parasite populations, i.e.
clones of the same parasite species (de Roode et al. 2005; Read
and Taylor 2001). When clones compete for resources on
exposure to host immune responses, their population dynamics
can be affected (de Roode et al. 2005). Thus clone competition
might affect host morbidity and transmission potential influ-
encing the emergence of traits such as virulence and drug
resistance. It has been postulated that reducing the number of
genetically mixed infections may have health benefits through
reduction of the level of within-host competition and hence the
selection for reduced virulence (Galvani 2003). The clinical
manifestations of malaria are quite diverse, ranging from
asymptomatic parasitaemia, mild malaria to potentially fatal
conditions such as severe anaemia, metabolic acidosis, coma
and multi-organ failure (Miller et al. 2002). Although the
molecular basis of severe malaria has been well studied in
recent years, determinants of the clinical outcomes of malaria
remain unknown (Conway 2007). Complex interactions of
host, parasite and environmental factors are thought to contrib-
ute to the clinical outcome of malaria (Miller et al. 2002). One
M. S. Kiwuwa (*) : J. Byarugaba
Department of Paediatrics, School of Medicine, Makerere
University College of Health Sciences, Kampala, Uganda
e-mail: mkiwuwa@yahoo.com
K. Fred
Department of Biochemistry, School of Biomedical Sciences,
Makerere University College of Health Sciences,
Kampala, Uganda
U. Ribacke :K. Moll :M. Wahlgren
Department of Microbiology, Tumor and Cell Biology (MTC),
Karolinska Institutet, Stockholm, Sweden
K. Lundblom :A. Färnert
Department of Medicine, Infectious Diseases Unit,
Karolinska Institutet, Stockholm, Sweden
Parasitol Res (2013) 112:1691–1700
DOI 10.1007/s00436-013-3325-3
aspect of virulence in malaria refers to the harm done to the
human host following an infection in terms of morbidity and
mortality (Read 2007). The main virulence factors include the
ability to induce binding of infected red blood cells (RBCs) to
the vascular endothelium (cytoadherence) and to non-infected
erythrocytes (rosetting) or to other infected erythrocytes (auto-
agglutination; Chen et al. 1998), and subsequent RBC micro-
vasculature sequestration (Miller et al. 2002). The evolution
from an uncomplicated to a severe infection such as cerebral
malaria is not well understood. It is likely that the expression of
specific binding phenotypes will result in distinct patterns of
sequestration and pathogenic consequences (Mackintosh et al.
2004). Some investigators have reported more frequent binding
to multiple receptors of isolates from children causing severe
malaria vs mild malaria (Heddini et al. 2001). Consequently
there is lack of clear understanding whether multiple adhesion
of parasitized RBCs found in patients with severe malaria is
due to the occurrence of several binding events arising from a
single clonal population of parasites, or if the observation is due
to several infecting clones exhibiting distinct receptor specific-
ities. The repertoire of multiple infections may also induce the
production of and/or the release of various pro-inflammatory
cytokines that may be more difficult to control by the immune
system, resulting in severe disease (John et al. 2008).
The relationship between the number of infecting clones in
P. falciparum, multiplicity of infection (MOI) and severity of
clinical episodes is not well understood and the findings have
been inconsistent (Table 1). Some studies have demonstrated a
higher MOI in severe cases (Ranjit et al. 2005; Rout et al.
2009) and in others similar numbers of genotypes per infection
between the categories have been observed (A-Elbasit et al.
2007; Conway et al. 1991; Durand et al. 2008; Kun et al. 1998;
Nielsen et al. 2002). Besides MOI, it is also not yet clear
whether there are gene polymorphisms that cause some P.
falciparum parasites to be inherently more virulent than others.
Some studies have reported an association of particular msp1
or msp2 allelic types and severe malaria (Ariey et al. 2001;
Kun et al. 1998), whereas others did not find such an associ-
ation (Durand et al. 2008; Robert et al. 1996; Rout et al. 2009).
Prior studies in Uganda have examined the relationship be-
tween MOI and the response to anti-malarial therapy or para-
site densities in areas of differing endemicity (Cattamanchi et
al. 2003; Kyabayinze et al. 2008; Peyerl-Hoffmann et al.
2001). However, no studies have been undertaken in Uganda
to compare MOI in mild and severe malaria among children.
The genetic diversity of P. falciparum parasites obtained from
children presenting with severe or mild (uncomplicated malar-
ia) from Kampala in Uganda was investigated. The aim of this
study was to examine whether the severity of malaria episode
was associated with multiplicity of infection, and/or a particu-
lar allelic family msp1 or msp2 genotype prior to initiation of
anti-malarial treatment. Polymorphisms within the four antigen
genes, namely the merozoite surface protein-1 (msp1), mero-
zoite surface protein-2 (msp2), glutamate-rich protein (glurp)
and circumsporozoite protein (csp) were analysed. The use of
multiple markers may enhance the detection of diversity at
Table 1 Multiplicity of infection and severity of malaria
Mean multiplicity of infection (MOI)
Number of isolates
Site (reference) Genotypic marker Uncomplicated malariaa Severe malariab P value
Gambia (Conway et al. 1991) msp1, msp2 2.04 (118) 2.11(35) >0.05
Senegal (Roberts et al. 1996) msp1, msp2, glurp, csp, hrp1 3.1 (30) 2.2 (56) <0.05
Gabon (Kun et al. 1998)c msp1, msp2 NR (100) NR (100) >0.05
Ghana (Nielsen et al. 2002) msp1, msp2, glurp 2.1 (28) 2.0 (34) >0.18
India (Ranjit et al. 2005)d msp1, msp2, glurp, hrp1 NR (40) NR (35) <0.001
Gabon (Mayengue et al. 2007) msp1, msp2 2.9 (30) 3.0 (30) >0.05
Sudan (A-Elbasit et al. 2007) msp2 1.53 (103) 1.5 (106) >0.05
Nigeria (Amodu et al. 2008) msp2 2.1 (144) 1.4 (131) <0.05
Madagascar (Durand et al. 2008) msp2 3.72 (134) 3.73 (102) >0.05
India (Rout et al. 2009) msp1, msp2 2.5 (48) 3.1 (48) 0.002
NR indicates not reported.
a UM, uncomplicated malaria is defined as acute falciparum malaria in the absence of danger signs or evidence of severe malaria
b SM, severe malaria denotes cerebral malaria, severe malarial anaemia, respiratory distress, prostration, hypoglycaemia or other (World Health
Organization 1990, 2000) criteria defining severe malaria.
c Severe malaria cases comprised of severe malarial anaemia (haemoglobin<5 g/dl) and hyperparasitaemic cases; mild malaria cases included for
haemoglobin levels >8 g/dl.
d Severe malarial anaemia defined as haemoglobin<7gm/dl; association of multiple allele frequency only significant for the msp2 allele.
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different polymorphic loci (Babiker et al. 1999). PCR genotyp-
ing methods were used to characterize parasite populations in
which allelic variants can be simply distinguished by size
following electrophoresis in agarose gels (Doolan 2000;
Wooden et al. 1993). Furthermore, in a secondary analysis of
a subset of samples, the conventional gel electrophoresis meth-
od was compared to fluorescent PCR coupled with high-
resolution capillary, electrophoresis (Liljander et al. 2009).
Previous studies have revealed better resolution for detection
of msp2 alleles by use of capillary electrophoresis (Falk et al.
2006; Liljander et al. 2009).
Methods
Study setting and participant recruitment
The study participants were recruited from the Paediatric
Outpatient Assessment Centre and Acute Care Units of
Mulago National Referral Hospital in Kampala and from
Kasangati Health Centre IV in Wakiso District. Kampala
District lies within Central Uganda. The district is bordered
by Wakiso District to the south, the west and the north, and
by Kira Municipality to the east. The coordinates of the
district are: 0°19′N 32°35′E at an altitude of 1,200 m.
Malaria in this area is meso-endemic, with two peaks fol-
lowing the rainy seasons in March to May and September to
November. Kampala features a tropical wet and dry climate.
The average maximum daytime temperature in January is
28 °C, dropping to an average maximum of around 25 °C in
July. Mean annual precipitation is 1,174 mm. Anopheles
gambiae is the predominant mosquito vector. The estimated
annual P. falciparum entomological inoculation rate (EIR)
was found to be six infective bites per person per year in the
neighbouring Jinja district (Okello et al. 2006). Mulago
Hospital provides services to Kampala’s population of about
1,720,000 (Uganda Bureau of Statistics, Statistical Abstract
2012) and surrounding districts plus upcountry referrals.
During December 2007 to September 2008, children aged
between 6 months and 6 years from the selected clinical
settings were consecutively recruited to participate in the
study according to the World Health Organization (WHO)
criteria for the classification of malaria severity (World
Health Organization 2000). The eligibility criteria for severe
malaria cases included: (1) fever (axillary temperature
≥37.5 °C) or history of fever in the previous 24 h, (2) P.
falciparum infection with a parasite density of at least 2,000
asexual forms per microlitre of blood identified microscop-
ically on thick blood smears, (3) no evidence of concomitant
febrile illness and (4) the presence of one of the following
clinical features: repeated convulsions (>2 in preceding
24 h), altered consciousness, lethargy, prostration, inability
to drink or breast feed, repeated vomiting, severe anaemia
(haemoglobin level <5.0 g/dl), respiratory distress (nasal
flaring, in-drawing [recession] of the bony structure of the
chest wall, or deep breathing) or jaundice. The inclusion
criteria for mild (uncomplicated) malaria cases were parasite
density ≥2,000 parasites/μl, fever (axillary temperature
≥37.5 °C) or history of fever in the previous 24 h, and
absence of danger signs or evidence of severe malaria.
Both severe and mild malaria patients were recruited simul-
taneously from each site. Patients with known chronic dis-
ease conditions, children receiving anti-retroviral therapy, or
had an intake of anti-malarial drugs within the preceding
2weekswere excluded.Written informed consent was obtained
from parents or legal guardians of children who provided a
blood sample for further studies prior to their enrolment. The
Ethics Committee of the Faculty of Medicine, Makerere
University and the Uganda National Council of Science and
Technology approved the study.
Clinical and laboratory investigations
Upon enrolment, detailed clinical histories and examina-
tions were undertaken from both groups of patients who
were followed up until recovery. All participants received
treatment according to the national treatment guidelines. A
series of biochemical, haematological and other pathologi-
cal investigations were performed at laboratories based in
Kampala (LMK and Makerere University Biochemistry lab-
oratories) and at Karolinska Institutet. Malaria was diag-
nosed by microscopy. Thick smears were prepared
following the Lambaréné method (Kremsner et al. 1988).
Each high-power field (HPF) of a thick smear was estimated
to be approximately 1/630 of a microlitre of blood (on a
standard microscope at ×1,000 magnification) and parasite
counts were estimated for 20 HPF or at least 100 HPFs
before declaring a smear negative. For internal quality con-
trol, 20 % of the slides were read by an independent mi-
croscopist. A third reader resolved discrepant results.
Clinical P. falciparum isolates (2–4 ml of venous blood)
were collected by venipuncture into EDTA-coated tubes
from patients before treatment was initiated (the procedure
did not unduly delay the treatment).
Isolation and purification of parasite DNA
Whole blood treated with EDTA anti-coagulant was layered
over a density gradient consisting of PolymorphprepTM,
(Axis-Shield) and centrifuged at 500×g for 35 min at room
temperature. This method can concentrate parasitized RBCs
effectively and recover a high level of malarial parasites
ensuring minimal contamination with human host WBCs.
Parasite DNA was then isolated from 200 μl of parasitized
packed cell volume (PCV) blood using the Easy-DNATM
Kit (Invitrogen), following the supplier’s recommendations
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with minor modifications. In brief, parasite genomic DNA
containing aqueous phase, once extracted with 25:24:1 phe-
nol/chloroform/isoamyl alcohol (Sigma), was treated with
RNase before two additional rounds of extraction and sub-
sequently the DNA concentration and quality were mea-
sured using a Nanodrop™ method (Thermo Fisher
Scientific). Parasite DNA was re-suspended in 20 μl of
nuclease free water and stored at −20 °C and later diluted
to standardized concentrations during performance of PCR
assays.
Genotyping of P. falciparum msp1, msp2, glurp
and csp genes by gel electrophoresis
The polymorphic genetic loci of msp1, msp2, glurp and csp
resulting from repetitive sequences where the number of a
given repeat unit can vary between parasite lines, were used
for genotyping of parasite populations in this study.
Furthermore, for msp1 and msp2, the presence of unique
sequences can be used to divide the variants into distinct
allelic families. The polymorphic repetitive regions block 2
of msp1 and block 3 of msp2 were amplified by nested PCR,
and RII repeat region of glurp by semi-nested PCR using the
primers described by Doolan (2000) and Snounou et al.
(1999). In the nest 1 reactions, primer pairs corresponding to
conserved sequences spanning the polymorphic regions of
each gene were included in separate reactions. The product
generated in the first reaction was used as a template in six
separate second nest 2 reactions, using in each case a specific
primer pair in order to determine the presence of allelic var-
iants from the K1, MAD20 and RO33 families of msp1 block
2, the 3D7/IC and FC27 families of msp2 repeats, and the RII
blocks of glurp. The sequence of the primers used to amplify
the central region of the csp gene were 5′-ATAGTAGATCAC
TTGGAGA-3′ (CSF) and 5′-GCATATTGTGACCTTG
TCCA-3' (CSR) using a non nested regular PCR approach
(Wooden et al. 1993). Each genotype was characterized by the
size corresponding to its PCR products following agarose gel
electrophoresis. The description of each isolate included the
number of genotypes and the size of the corresponding PCR
products within the isolate, as well as allelic types (i.e., fam-
ilies) of msp1 and msp2. Each polymorphic domain was
amplified from 1 μl of DNA solution (~10 ng/μl) in a 25 μl
reactionmixture containing 250 nMof each primer (except for
glurp nest 1 primers which were used at a concentration of
125 nM), 2 mM MgCl2, 125 μM of each dNTP, 0.5 U Taq
polymerase (Invitrogen) and PCR buffer.
The thermocycling conditions in thermocycler (Applied
Biosystems) for msp1, msp2 and glurp nest 1 reactions were
as follows: 5 min at 95 °C, followed by 25 cycles for 2 min at
58 °C, 2 min at 72 °C and 1 min at 94 ° C then final annealing
for 2 min at 58 °C and final extension of 5 min at 72 °C. For
the nest 2 PCR reactions, similar conditions were used for
denaturing and extension, with the annealing temperature set
at 61 °C for 30 amplification cycles. Similar PCR amplifica-
tion reaction conditions were used for the csp locus with the
annealing temperature set at 55 °C for 35 cycles. The ampli-
fied PCR products were either stored at +4 °C or analysed
immediately by electrophoresis on a 2 % molecular grade
agarose gel (Biorad) and visualized by UV transilluminator
after gel red (Biotium) staining. The sizes of the PCR products
were estimated using Imagelab software version 3.0 (Biorad)
with the sizes computed automatically by the software based
on the 100 base pairs DNA ladder calibrator (Fermentas).
Fragment analysis by capillary electrophoresis
For the comparison of genotyping methods, a subset of
DNA samples was randomly selected from the original
sample and genotyped for msp2 by fluorescent-label PCR
(Liljander et al. 2009). In brief, the PCR included the same
initial amplification of the outer msp2 domain as described
above, followed by two separate nested reactions with fluo-
rescently labelled primers for the two allelic families of
msp2 (FC27 and IC/3D7). Amplified products were ana-
lysed by capillary electrophoresis in a DNA sequencer
(3730, Applied Biosystems) using GeneMapper software
(Applied Biosystems).
Definitions
The detection of a single PCR fragment for each locus was
classified as an infection with one parasite genotype (single
genotype infection). The detection of more than one PCR
fragment for either msp1, msp2, glurp or csp loci (i.e. an
infection with more than one parasite genotype) was con-
sidered as multiple P. falciparum genotype infection. For a
particular sample analysed, the number of (bands) observed
for each of the genetic markers is determined (which for
msp1 and msp2 included adding the bands observed for the
K1, MAD20 and RO33 families as well as the FC27 and
3D7/IC families respectively) Doolan (2000). MOI was
defined as the number of parasite genotypes per infected
patient, calculated by combining the msp1, msp2, glurp and
csp PCR genotyping results. The maximum number of
bands detected whatever the locus was considered as the
MOI of that infection.
Statistical analysis
The mean MOI was compared between mild and severe cases
using the non-parametric Mann–Whitney U test with adjust-
ment for ties. The proportions of alleles observed at each
genetic locus within each group were compared using the
Chi-square test statistic. Odds ratios and 95 % confidence
intervals were computed as measures of effect. P values less
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than 0.05 were considered significant. All statistical analyses
were performed using SPSS statistical software, version 18.0.
Results
Clinical characteristics of the malaria cases at presentation
The study population comprised 164 patients of whom 82
(50 %) had severe malaria and 82 (50 %) mild malaria accord-
ing to the WHO classification criteria. The main clinical
manifestations and characteristics of the patients are summa-
rized in Table 2. There was a tendency of lower age in children
with severe malaria compared to mild malaria (mean 28.7 and
33 months respectively, P=0.227). Geometric mean parasite
density was higher in patients with severe malaria compared
to that in mild cases (32,064 vs 12,110/μl, P=0.02). The
distribution of ABO blood groups was similar in mild and
severe cases. In the severe malaria category, 16 (19.5 %)
presented with respiratory distress as the most common syn-
drome, 9 (12.9 %) had severe malaria anaemia and 12
(15.6 %) had features suggestive of cerebral malaria (deter-
mined as altered level of consciousness with asexual P. falci-
parum parasitaemia and no other evident aetiology of coma).
Three patients with severe malaria died. None of the patients
with mild malaria developed features of severe disease and all
of them were clinically cured after treatment with artemether/-
lumefantrine. The patients with severe malaria were initially
treated with intravenous quinine followed by administration
of oral quinine.
Genotyping of different antigens
Blood samples were available for 164 of the patients
(82 mild and 82 of severe malaria cases) for whom genotyp-
ing was performed. PCR amplification was successful in 97,
98.8, 97 and 87.2 % of samples for msp1, msp2, glurp and
csp respectively; and in 100 % of samples when results for
the four genes were combined.
Genetic diversity of infection
Of the 164 P. falciparum isolates genotyped by gel electro-
phoresis, 131 (80.4 %) comprised multiple genotypes.
Among children with mild malaria 19 (23 %) were carrying
single genotypes and 63 (77 %) had multiclonal infections
(range 2–7). In the severe malaria group, 13 (15.8 %)
patients had single and 69 (84.2 %) had multiple genotypes
(range 2–8). Severe malaria cases were more likely to have
≥3 genotypes per infection compared to mild malaria cases,
OR 2.5 (95 % CI, 1.3–4.9, P=0.009). When selecting the
maximum number of alleles in the respective markers for
each sample, the mean MOI was higher in severe malaria
cases compared to that in mild malaria cases (3.7 vs 3.0
respectively, P=0.002). A high degree of genetic diversity
was detected at the msp1 and msp2 loci whereas less
Table 2 Comparison of baseline
clinical features among children
with mild and severe malaria,
Kampala, Uganda
Values are number (%) unless
otherwise stated, unarousable
coma indicates Blantyre coma
scale <3.
Where total variable frequencies
are <100 %, data was unavail-
able for some study participants.
aNasal flaring, in drawing
(recession) of the bony structure
of the chest wall,
or deep breathing
bAltered level of consciousness
with asexual Plasmodium
falciparum parasitaemia and no
other evident etiology for coma.
Characteristic Severe malaria (n=82) Mild malaria (n=82) P
Age, mean (SD), mo 28.7 (21.7) 33.0 (23.5) 0.227
Male gender 50 (61) 52 (63.4) 0.747
Axillary temperature, mean (SD), °C 38.6 (1.1) 37.8 (1.1) <0.001
Malaria rapid diagnostic test 57 (96.68) 67 (95.7) 0.776
Geometric mean parasite density/μl 32,064 12,110 0.02
Hyperparasitaemia (>250,000/μl of blood) 8 (13.8) 2 (2.6) 0.014
>1 Convulsions in last 24 h 26 (31.7) 0 (0) <0.001
Respiratory distressa 16 (19.5) 0 (0) <0.001
Clinical jaundice 14 (17.1) 0 (0) <0.001
Severe anaemia, Hb<5 g/dl 9 (12.9) 0 (0) 0.001
Unarousable coma 1 (1.2) 0 (0) 0.316
Cerebral malariab 12 (15.6) 0 (0) <0.001
Splenomegaly 27 (33.3) 3 (3.7) <0.001
Circulatory collapse 7 (9.0) 0 (0) 0.006
Total leucocyte count (×103), mean (SD) 10.8 (5.1) 9.7 (4.2) 0.181
Platelet count (×103) mean (SD) 169.5 (106.7) 203.8 (124.8) 0.103
ABO blood groups
(A, B, AB) 38 (52.1) 40 (50.0) 0.800
(O) 35 (47.9) 40 (50.0)
Blood transfusion 11 (13.4) 0 (0) 0.001
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diversity was observed at the glurp and csp loci (Table 3).
The msp1 RO33 and msp2 FC27 allelic families were
detected at higher frequencies in severe malaria compared
to mild malaria cases, although these differences are not
statistically significant. The distribution of the other family
specific alleles among mild and severe malaria cases was
not significantly different. The allele frequency within the
different genetic markers is shown in Fig. 1. There was a
trend towards a higher multiplicity of infection at younger
age groups. Age did not however have an effect on the mean
multiplicity of infection between mild and severe malaria
cases, P=0.487 (Fig. 2). Considering the classification of
severe malaria according to the three major syndromes,
severe malarial anaemia combined with respiratory distress
exhibited a higher MOI compared to cerebral malaria alone,
(4.2 vs 3.4 respectively, P=0.231) based on data from gel
electrophoresis. However, this syndromic classification ap-
proach was restricted to only 43/82 of the severe malaria
cases.
msp2 genotyping using gel vs capillary electrophoresis-
A supplementary analysis was undertaken on a subset of
133 samples using fluorescent-label PCR msp2 genotyping
followed by capillary electrophoresis. The analysis indicat-
ed a modest agreement on the observed number of alleles
when compared with the conventional gel electrophoresis
method (kappa=0.07). Irrespective of the method used,
there was no significant difference in MOI between the mild
and severe malaria cases with regard to msp2 diversity alone
and nor did we detect a better resolution with the capillary
method (Table 4).
Discussion
The main finding of this study is that the mean number of
circulating P. falciparum genotypes in severe malaria cases
was higher than that of isolates from the mild cases, when
selecting the highest number of alleles detected in any of the
four antigen genes (msp1, msp2, csp and glurp). The diversity
was higher within the msp1 and msp2 loci compared to glurp
and csp loci presumably because the latter are less poly-
morphic. These findings seem to suggest that the use of single
genetic markers may underestimate the diversity of infections.
The observed results of a higherMOI are consistent with those
of smaller studies done in India (Ranjit et al. 2004, 2005; Rout
et al. 2009) but in contrast to reports from Senegal (Robert et
al. 1996) or Nigeria (Amodu et al. 2008), where the severe
malaria category had a lower MOI than the mild type; and also
studies from Ghana (Nielsen et al. 2002), Gabon (Mayengue
et al. 2007), Sudan (A-Elbasit et al. 2007) and Madagascar
(Durand et al. 2008) where comparable levels of MOI were
observed among mild and severe malaria cases. The studies in
India included adult patients with severe malaria in whom
severe complications developed following initial treatment at
rural health centres (Ranjit et al. 2004, 2005; Rout et al. 2009).
Robert et al. (1996) included adults and children as well as
French military personnel among the locals. Similarly, the
study population of Durand et al. (2008) comprised of both
adults and children. The initial treatment among the study
Table 3 Genotyping of msp1 and msp2, glurp and csp antigen genes among mild and severe malaria cases using gel electrophoresis (n=164)
Genes Severe malaria (n=82) Mild malaria (n=82) P value
Positive na (%) Fragment size range bp MOI Positive na (%) Fragment size range bp MOI
msp1 3.2 2.5 0.005b
K1 68 (82.9) 150–340 70 (85.4) 130–135 0.833c
MAD20 41 (50) 180–350 41 (50) 100–310 1.000c
RO33 40 (48.8) 140–270 31 (37.8) 130–300 0.157c
msp2 2.7 2.3 0.050b
FC27 71 (86.8) 220–590 64 (78.0) 230–580 0.166c
IC 76 (92.7) 300–750 76 (92.7) 300–750 1.000c
glurp 80 (97.6) 360–1300 1.7 79 (86.3) 360–1250 1.6 0.297b
csp 74 (90.2) 540–1200 1.19 69 (84.1) 550–1020 1.07 0.041b
Overall MOId 3.7 3.0 0.002b
a Number of children with detection of respective allele types, Mean MOI (multiplicity of infection).
bP values from Mann–Whitney U test
c Chi-square tests
d Determined by selecting the highest number of alleles detected in any of the four antigen genes.
Fig. 1 Frequency distribution of allele types among mild and severe
clinical cases: a maximal number of alleles considering all four
markers, b msp1 alleles, c msp2 alleles, d glurp alleles and e csp
alleles. Count indicates number of children in the respective groups
b
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cases from the different sites could have reduced the diversity
of the isolates (Amodu et al. 2008; Durand et al. 2008; Ranjit
et al. 2004, 2005; Robert et al. 1996; Rout et al. 2009).
Additionally, differences in transmission intensity according
to study sites may result in variable results when comparing
MOI from different groups (A-Elbasit et al. 2007; Amodu et
al. 2008; Robert et al. 1996). Differences in genotyping meth-
ods and/or interpretation of data as well as the heterogeneity of
the various study populations may also partly explain the
variability of results among studies. Due to the fluctuation of
parasite density and complexity, a single peripheral blood
sample may not reveal the full complexity of the parasite
population harboured by an individual (Farnert 2008).
Firstly, blood samples were collected once and secondly,
PCR methods may fail to detect minority parasite strains that
are not present in the peripheral blood at the time of sampling.
The observation that children with non-cerebral malaria had
higher MOI compared to those with cerebral malaria would
require a larger study for confirmation (Montgomery et al.
2006). Children with severe malaria might have more seques-
tration (e.g. to capillaries in the brain) of certain parasite
populations than mild malaria cases (Dembo et al. 2006;
Montgomery et al. 2006). Alternatively MOI may also be
regarded as an indicator of immune status in other vulnerable
populations such as pregnant women. Pregnancy and low
parity being associated with a higher MOI (Schleiermacher
et al. 2001). In non-immune travellers, a higher MOI was
similarly observed among severe malaria cases (Nicastri et
al. 2008). Among children in Gabon, samples with the highest
MOI significantly corresponded with lower antibody
responses to specific asexual stage antigens, implying that
low levels of acquired immunity may be related to the poor
capacity to control infection (Mayeungue et al. 2009). Severe
malaria may also be associated with higher parasite multipli-
cation and rosette formation rates (Chotivanich et al. 2000; Le
Scanf et al. 2008). However, in asymptomatic carriers in high
endemicity areas, multiclonal infections have also been asso-
ciated with a reduced risk of subsequent clinical malaria
(Bereczky et al. 2007). For the secondary comparison of the
gel electrophoresis method with high-resolution capillary
electrophoresis (Liljander et al. 2009), no differences were
observed with regard to MOI in severe or mild cases and
neither was an improved resolution detected with the capillary
method. Limitations in the sample size and use of a sole
genetic marker may partly explain lack of a difference in the
subgroup analysed. Further evaluation of a larger set of sam-
ples using additional polymorphic markers would assess alle-
lic diversity more accurately using the capillary method
(Mwingira et al. 2011).
The data of A-Elbasit et al. (2007), Durand et al. (2008)
and Rout et al. (2009), in which no significant association
was found between the occurrence of a specific genotype
and the severity of malaria, support our findings. In French
Guiana, it was demonstrated that a specific msp1 allele
bearing a specific variant gene (var-D) was associated with
severe malaria (Ariey et al. 2001). However, this study was
performed in a limited geographical area where parasite
genetic diversity is reported to be low and thus, their results
cannot be extrapolated to other areas. Ranjit et al. (2005)
reported that MAD20/msp1 and 3D7/msp2 alleles were
over-represented in severe malaria cases in Orissa (India).
Comparison of these findings with those of other groups
demonstrates that the distribution of P. falciparum geno-
types according to clinical severity seems to differ across
geographic regions. A longitudinal study to further assess
the extent of morbidity in relation to parasitic status, clonal
diversity and host immune responses may provide more
insight into the dynamics of virulence evolution in multiple
parasite strain infections (Mayor et al. 2003).
Fig. 2 Mean number of P. falciparum genotypes among children with
mild and severe malaria according to age group. Error bars indicate
95 % confidence intervals
Table 4 Comparison of msp2 genotyping multiplicity of infection among mild and severe malaria cases generated by two genotyping methods
Genotyping method Severe malaria (n=68) Mild malaria (n=65) P value
PCR and gel electrophoresis 2.51 (0.97) 2.74 (0.96) 0.183
Fluorescent PCR and capillary electrophoresis 2.43 (1.42) 2.25 (1.24) 0.435
Values are mean (SD) unless otherwise indicated
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Conclusions
When selecting the highest number of alleles within the four
analysed antigen genes, a higher MOI was detected in
children with severe malaria. The differences in diversity
between severe and mild cases were not as prominent within
the individual markers and did not appear to be restricted to
some particular genotypes or allelic family msp1 or msp2.
Capillary electrophoresis offers the prospect to determine
allelic diversity more accurately. Establishing the relation-
ship between multiple clone infections, immune status,
host genetic factors and the subsequent risk of clinical
malaria will provide more insight into parasite virulence
mechanisms.
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